The manufacturer of Yaz and Yasmin will pay more than $110 million to settle nearly 500 lawsuits alleging that Yasmin caused blood clots in patients who used the drug. Bayer Pharmaceuticals is facing more than 11,000 Yasmin and Yaz lawsuits, according to a recent filing by the company.